Fabrinet (FN) Stock
Precision contract manufacturer for optical and electronic assemblies. Here's the price, business snapshot, and what's worth knowing about Fabrinet in September 2026.
Fabrinet (FN) is a precision contract manufacturer specialising in complex optical, electro-mechanical and electronic assemblies for customers in telecommunications, medical, industrial and automotive markets. Headquartered in Thailand, the company combines cleanroom manufacturing, precision optical packaging and assembly services to serve major original equipment manufacturers (OEMs). Key drivers include demand for high-performance optical modules, medical devices and other specialised products where quality and scale matter. Investors should note revenue can be lumpy because of customer concentration and cyclical end-markets, and the business is sensitive to supply‑chain constraints and capital expenditure to expand capacity. Historically Fabrinet has delivered attractive gross margins for a contract manufacturer, but future performance will depend on customer wins, industry cycles and execution. This summary is educational only and not personalised investment advice; values can rise and fall and past performance is not a reliable indicator of future results. Consider suitability and diversification before investing.
Fabrinet (FN) Stock Forecast
Analyst price target, next 12 months
$545.77
+35.5% vs today's $402.92
Price range over the last 12 months
Close to its 12-month low
Analysts covering Fabrinet have a consensus 12-month target of $545.77, above the current price of $402.92.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 24 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Fabrinet's stock with a target price of $545.77, indicating strong potential growth.
Financial Health
Fabinet is showing strong revenue and cash flow, although its profit margins are relatively low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Optics and Medical Demand
High-performance optical modules and medical devices can drive growth, though sales may be cyclical and linked to a few large customers.
Global Manufacturing Footprint
Operations in Thailand with global customers provide scale advantages, but expose the firm to geopolitical and supply‑chain risks.
Execution and Margins
Fabrinet's engineering capabilities support healthy margins for complex work, yet maintaining margins depends on execution, pricing and capital investments.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
